Atrial Fibrillation, Obesity
Conditions
Brief summary
Obesity is a well-established risk factor for the development of atrial fibrillation (AF), while the reduction of body weight was shown to reduce the risk of AF. However, little is known about the effect of different weight-reducing interventions on AF burden. The study will evaluate the effect of a complex program aimed at weight reduction on AF burden in subjects after catheter ablation for AF and at least 1st degree obesity. This will be investigated in randomized study design and compared with patients receiving standard care without specific obesity-related intervention. The weight loss program will consist of diet, lifestyle and exercise counselling and, in selected subjects, also bariatric surgery in order to achieve a sustained weight loss of \>10% of initial body weight. Secondary aims include identification of patient phenotypes with the most benefits from weight reduction as well as elucidation of potential pathomechanisms linking obesity and AF, with the main focus being on low-grade inflammation. The project will help to define the optimal weight-reducing regimen in AF and to tailor the interventions to individual patient needs.
Interventions
BEHAVIORALPhysician-lead complex program of weight-reducing interventions
A structured motivational and goal directed program will be used for weight reduction involving physicians, nutritionists, educators and physiotherapists. Initially, based on the input data provided by the patient an individual nutritional plan will be designed with the aim of reducing caloric intake by 10%. Low-intensity aerobic exercise for 30 min will be prescribed 3-times a week with the aim of increasing the frequency to 5-times a week and participants will be offered the possibility to participate in regular physiotherapist-lead group exercises. Patients will be required to maintain a diet and physical activity diary. Regular reviews will be scheduled every 3-6 months according to the actual weight loss.
Bariatric surgery will be performed based on actual medical indication and independently of patient's participation in the study. Sleeve gastrectomy was selected as the currently most frequent restrictive type of bariatric surgery with a proven efficacy on weight reduction, metabolic status and low-grade inflammation
Sponsors
Martin Haluzik
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Paroxysmal or persistent AF scheduled for primary RF ablation * BMI ≥30 kg/m2 * Age 18-70 years * Informed consent to the study
Exclusion criteria
* Previous ablation for AF * Myocardial infarction, stroke or pulmonary embolism \< 3 months prior to inclusion * left ventricular ejection fraction \< 40% * Left atrium diameter \> 55 mm * Active thyroid disease * Chronic kidney disease stage IV-V (eGFR \< 0.5 ml/s) * Chronic liver disease * Active malignancy * Inability to comply with study procedures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Atrial fibrillation burden | 18 months | Atrial fibrillation burden expressed as % of total monitoring time at final visit |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Progressive reduction of AF burden between 12- and 18-month follow up visit | 18 months | Progressive reduction of AF burden between 12- and 18-month follow up visit |
| hsCRP | 18 months | — |
| Number of AF episodes on 14-day Holter monitoring | 18 months | Number of AF episodes on 14-day Holter monitoring |
| Concentration of atrial natriuretic peptide (ANP) | 18 months | — |
| Concentration of brain natriuretic peptide (BNP) | 18 months | — |
| Epicardial adipose tissue volume | 18 months | Assessed by transthoracic echocardiography |
Countries
Czechia
Contacts
Primary ContactKristyna Stolbova, MD
Outcome results
None listed